Moderna Inc (MRNA)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 13,854,000 13,455,000 16,949,000 18,863,000 19,123,000 17,992,000 17,985,000 17,075,000 14,145,000 10,124,000 6,704,000 3,838,000 2,561,000 2,760,000 2,947,000 1,641,000 1,175,000 1,248,190 1,334,960 1,442,320
Debt-to-capital ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $—K ÷ ($—K + $13,854,000K)
= 0.00

The debt-to-capital ratio of Moderna Inc has been relatively stable over the past eight quarters, ranging from 0.04 to 0.06. This ratio represents the proportion of the company's total debt in relation to its total capital, which includes both debt and equity. A lower ratio indicates a lower level of financial leverage and risk, suggesting that Moderna relies more on equity financing rather than debt to fund its operations and investments. Overall, the consistent and relatively low debt-to-capital ratio demonstrates Moderna's conservative approach to managing its capital structure and financial risk.


Peer comparison

Dec 31, 2023


See also:

Moderna Inc Debt to Capital (Quarterly Data)